Figueiredo, A., Atkins, H., Mallick, R., Kekre, N., Kew, A., & McCurdy, A. (2020). Cyclophosphamide–bortezomib–dexamethasone compared with bortezomib–dexamethasone in transplantation-eligible patients with newly diagnosed multiple myeloma. Curr Oncol.
Styl ChicagoFigueiredo, A., H. Atkins, R. Mallick, N. Kekre, A. Kew, a A. McCurdy. "Cyclophosphamide–bortezomib–dexamethasone Compared With Bortezomib–dexamethasone in Transplantation-eligible Patients With Newly Diagnosed Multiple Myeloma." Curr Oncol 2020.
Citace podle MLAFigueiredo, A., et al. "Cyclophosphamide–bortezomib–dexamethasone Compared With Bortezomib–dexamethasone in Transplantation-eligible Patients With Newly Diagnosed Multiple Myeloma." Curr Oncol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..